Posted On: 08 Jul 2026
The European Patent Office has issued an Intention to Grant for a patent application covering proprietary applicator technology used with sofpironium topical gel, 12.45% (Sofdra®) into May 2039, enhancing potential ex-US commercialisation pathways.